Successful Completion of Retail Entitlement Offer
Filed with ASX · · 2 pages · English
Paradigm Biopharmaceuticals Ltd. on 6ix
Story so far
Earlier from Paradigm Biopharmaceuticals
- Paradigm Corporate Update - May 2019
- Quarterly Report and Appendix 4C - quarterly
- Completion of Institutional Entitlement Offer
- PAR Accelerated Non-Renounceable Rights Issue Offer Booklet
- Paradigm Confirms Capital Raise Commitments
Later from Paradigm Biopharmaceuticals
- PAR corrects AFR article
- PAR reports consistent pain reduction in knee OA of patients
- PAR reports successful Ross River phase 2 clinical trial
- Paradigm EOFY Update
- Appendix 4C - quarterly
Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.
Follow Paradigm Biopharmaceuticals